Jul 2026
Pan-cancer characterization of the pyrimidine catabolic enzyme UPB1 identifies a tumor-suppressive prognostic biomarker in skin cutaneous melanoma.
It is suggested that UPB1 functions as a tumor-suppressive factor linked to pyrimidine catabolism and may serve as a prognostic biomarker, particularly in skin cutaneous melanoma (SKCM).
Yin Men, Yi Shao, Yong-Feng Chen et al.
· Naunyn-Schmiedeberg's Archiv... · 0 citations